Rodrigo Silva

Rodrigo Silva is a highly experienced scientist in the field of immunology, currently serving as a Senior Scientist at ImmunityBio, Inc. since November 2023. Prior to this role, Rodrigo held the position of Senior Scientist at Artiva Biotherapeutics from February 2022 to April 2023, and Principal Scientist at NKGen Biotech, Inc. from April 2021 to January 2022. Additional experience includes a Scientist role at aTyr Pharma, a Postdoctoral Associate at The Scripps Research Institute, and Postdoctoral Researcher at Universidade Estadual de Campinas. Education includes a Doctor of Philosophy (PhD) in Immunology from Baylor College of Medicine and Universidade Estadual de Campinas, as well as a Master of Science in Immunology from both Universidade Estadual de Campinas and Karolinska Institutet, complemented by a Bachelor of Science in Pre-Medicine from the University of Central Arkansas.